본문바로가기
Q
U
I
C
K

Business

SK bioscience’s effort reaches beyond development and manufacture of premium vaccines
and extends to working with domestic and overseas partners to create a healthy future for mankind.

Outsourced products

Boostrix prefilled syringe 사진

Boostrix prefilled syringe

  • ClassificationPrescription medicine
  • Therapeutics classificationAdsorbed diphtheria for adults, tetanus toxoid and purified pertussis combination vaccine
  • Ingredients/contentDiphtheria toxoid, pertussis toxoid
  • Import license holderGlaxoSmithKline PLC
  • Co-distributorSK Bioscience Co., Ltd.
Description

Prefilled syringe containing white suspension in which white pallet and colorless and transparent supernatant are observed when stored

Dosage Forms and Strengths

Diphtheria toxoid (strain name: Mass 8 strains), pertussis toxoid (strain name: Tohama strain, phase 1), inactivated pertussis 69kDa outer membrane protein (strain name: Tohama strain, phase 1), inactivated pertussis filamentous hemagglutinin (strain name: Tohama strain, phase 1), tetanus toxoid (strain name: Massachusetts strain)

Indications and Usage

Prevention of diphtheria, tetanus and pertussis in children 10 years of age or older and adults

Dosage and Administration
  • 1 booster dose shall be given for children at 10 years of age or older and adults who have completed all recommended vaccination schedule of diphtheria/tetanus/toxoid and purified pertussis combination vaccine (DTaP) for children during infancy and childhood. However, for individuals who received a vaccine containing diphtheria/tetanus/toxoid should avoid receiving this vaccine within 5 years after the vaccination.
  • Injection a single dose (0.5 mL) intramuscularly into deltoid muscle, and do not inject intravascularly.
  • Mix sufficiently before use.
  • In case of having wound that is prone to autologous tetanus that requires tetanus toxoid (e.g., wound contaminated with dust, feces, soil and saliva; penetrating injury, etc.), this vaccine may be used as an adult diphtheria-tetanus vaccine if the individual has not been vaccinated with tetanus toxoid within 5 years.
    (Note: This vaccine cannot be used for basic vaccinations for infant and child. In other words, the standard vaccination for infancy and childhood should use DTaP for children.)
  • For infants aged 7-23 months who have not been vaccinated, give 2-dose series with 0.5 mL each.
    The second dose should be given at an interval of 3 months or longer after the first dose and when the infants are at 1 year of age or older.
    • For children aged 2 years or older to adults aged 55 years or younger, administer 0.5 mL once.
  • The necessity and timepoint of booster dose of this vaccine have not been decided yet.
How Supplied

1 prefilled syringe/box [prefilled syringe (0.5 mL)], 10 prefilled syringe/box [prefilled syringe (0.5 mL)], single-use needle attached

Storage
  • 1) Keep refrigerated (2-8°C) away from light.
  • 2) Do NOT freeze. Dispose if frozen.
  • 3) This vaccine is stable only for 8 hours at 21°C once removed from the fridge.